What is being recalled and why?

Medtronic MiniMed recalls 60,880 insulin pumps because the devices can over-deliver or under-deliver insulin when the pump height changes relative to the infusion site. This can cause serious health risks.

Which models are affected?

MMT-1714, MMT-1715, MMT-1754, MMT-1755, all under the MiniMed 630G line.

What should I do if I own one?

Stop using the device immediately and follow the recall instructions. Contact Medtronic MiniMed or your healthcare provider for next steps.

Will I get a replacement or refund?

Medtronic states recalls include steps for refund or replacement as part of the recall process. Follow the manufacturer’s instructions.

How will I know what to do next?

A recall notification by letter outlines required actions. Contact your clinician or Medtronic for guidance.

Are there symptoms I should watch for?

Over-delivery can cause hypoglycemia symptoms. Under-delivery can cause hyperglycemia and ketoacidosis. Seek medical attention if symptoms occur.

Is this recall limited to the United States?

The recall is worldwide, including the United States and many countries.

How long will refunds or replacements take?

Processing times vary by recall and region. Follow Medtronic guidance and monitor for updates.

Do I need to dispose of the device myself?

Follow the recall instructions. Do not dispose of devices without official guidance.

Should I contact my healthcare provider first?

Yes. Your clinician can advise on next steps and interim management.

What about insulin supply and management during recall?

Use alternative methods under medical supervision until guidance is provided.

Where can I find more information?

Refer to the FDA recall page and Medtronic recall notices for official details.

HIGHFebruary 13, 2026

Medtronic MiniMed 630G Insulin Pumps Recalled in 2026 for Insulin Delivery Errors (60,880 Units)

Medtronic MiniMed recalled 60,880 insulin pumps sold worldwide through healthcare providers and medical distributors, including the MiniMed 630G line. The defect is gravity related and can cause insulin over-delivery or under-delivery when the pump height changes relative to the infusion site. Patients should stop using the pumps immediately and follow recall instructions.

Quick Facts at a Glance

Recall Date: February 13, 2026
Hazard Level: HIGH
Brand: Medtronic MiniMed
Category: Health & Personal Care
Sold At: Multiple Retailers
Geographic Scope: 1 states
At-Risk Groups: GENERAL

Hazard Information

All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

The MiniMed 630G insulin pump is a wearable device that delivers insulin to manage diabetes, typically used with continuous glucose monitoring systems for automated delivery.

Why This Is Dangerous

The pump can deliver incorrect insulin doses when its height relative to the infusion site changes. Gravity affects pressures, leading to over-delivery or under-delivery.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

The recall affects tens of thousands of devices worldwide. Consumers must stop using affected pumps and follow guidance from Medtronic and clinicians.

Practical Guidance

How to identify if yours is affected

Check model numbers MMT-1714, MMT-1715, MMT-1754, MMT-1755.
Review whether your pump was part of the recalled lot by consulting Medtronic or your clinician.
Inspect pump height during use relative to infusion site.

Where to find product info

Recall notice and user guides from Medtronic and the FDA recall page list the affected models and steps.

What timeline to expect

Refunds or replacements follow Medtronic's recall process; timelines vary by locale.

If the manufacturer is unresponsive

Escalate to Medtronic customer support.
File a complaint with the FDA if the company is unresponsive or addresses are not provided.

How to prevent similar issues

Avoid using affected pumps; ensure replacement devices are properly configured.
Stay updated on firmware or software updates if applicable.
Verify device and infusion site setup per clinician guidance.

Documentation advice

Keep the recall notice, model numbers, purchase records, and all correspondence with Medtronic for your records.

Product Details

Model numbers: MMT-1714, MMT-1715, MMT-1754, MMT-1755. Product: MiniMed 630G Insulin Pump. Sold worldwide through healthcare providers and medical distributors. Sold since the MiniMed 630G line was in use prior to the recall. Price: Not disclosed.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

60,880 units recalled
Worldwide distribution including US states and many countries
Models affected include MMT-1714, MMT-1715, MMT-1754, MMT-1755
Immediate-use stop required; follow recall instructions

View Original Recall on FDA - Medical Devices

Browse More Recalls

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH

Severity Score

9/ 10

Affected Groups

GENERAL

Injury Types

OTHER

Product Classification

CategoryHealth & Personal Care › Medical Devices

Product TypeInsulin Pump

Product Details

Brand

Medtronic MiniMed

Related Recalls

Health & Personal Care

HIGH

Medtronic MiniMed 780G Insulin Pump Recalled for 453,144 Units Worldwide (2026)

Medtronic recalled 453,144 MiniMed 780G insulin pumps worldwide after reports of unintended insulin delivery when the pump height changes relative to the infusion site. The defect stems from gravity-driven pressure changes affecting hydrostatic delivery. Patients and caregivers should stop using the devices immediately and follow the recall notice, contacting Medtronic MiniMed or their clinician’s

Feb 13, 2026

Medtronic MiniMed

All Medtronic

Health & Personal Care

HIGH

Medtronic MiniMed 530G Insulin Pumps Recalled for Delivery Errors in 2026 (13,429 Units)

Medtronic recalled 13,429 MiniMed insulin pumps worldwide after identifying unintended insulin delivery errors. The issue occurs when the pump height relative to the infusion site changes, causing over-delivery or under-delivery of insulin. Patients should stop using the device and contact Medtronic for instructions.

Feb 13, 2026

Medtronic MiniMed

All Medtronic

Health & Personal Care

HIGH

Medtronic MiniMed 740G Insulin Pump Recalled for 24,946 Units Worldwide (2026)

Medtronic MiniMed recalled 24,946 MiniMed 740G insulin pumps worldwide after identifying unintended insulin delivery when the pump height changes relative to the infusion site. The defect can cause over-delivery or under-delivery of insulin due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed for instructions on recall steps, refunds or a swap

Feb 13, 2026

Medtronic MiniMed

All Medtronic

Health & Personal Care

HIGH

Medtronic MiniMed Paradigm Revel Insulin Pumps Recalled: 26,647 Units Worldwide (2026)

Medtronic MiniMed recalled 26,647 Paradigm REAL-Time Revel insulin pumps distributed worldwide, including in the United States. A design flaw can cause insulin to be over- or under-delivered when the pump height changes relative to the infusion site. Patients and health providers should stop using the device immediately and follow the manufacturer’s recall instructions. The recall covers Paradigm,

Feb 13, 2026

Medtronic MiniMed

All Medtronic

Health & Personal Care

HIGH

Medtronic MiniMed 720G Insulin Pump Recall 2026 Affects 37,458 Units Worldwide

Medtronic MiniMed recalled 37,458 insulin pumps sold worldwide through healthcare providers, including the MiniMed 720G, after finding that a pump raised above or lowered relative to the infusion site can deliver insulin too much or too little. The defect stems from changes in gravitational force affecting hydrostatic and hydrodynamic pressures at the infusion site. Patients should stop using the

Feb 13, 2026

Medtronic MiniMed

All Medtronic

Health & Personal Care

HIGH

Medtronic MiniMed Paradigm Veo Insulin Pump Recalled for 55,724 Units (2026)

Medtronic MiniMed recalls 55,724 Paradigm REAL-Time Veo insulin pumps distributed worldwide. The pumps can deliver too much insulin when raised or too little when lowered relative to the infusion site due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed or their healthcare provider for instructions and refunds.

Feb 13, 2026

Medtronic MiniMed

All Medtronic

Health & Personal Care

HIGH

Medtronic MiniMed 700G Insulin Pump Recalled for Insulin Delivery Errors (13,811 Units, 2026)

Medtronic MiniMed recalled 13,811 MiniMed 700G insulin pumps sold worldwide through multiple retailers. The pumps can deliver too much or too little insulin when the pump height relative to the infusion site changes due to gravity. Consumers should stop using the device and follow recall instructions in the letter notice sent to affected users.

Feb 13, 2026

Medtronic MiniMed

All Medtronic

Health & Personal Care

HIGH

Medtronic MiniMed Paradigm Real-Time Insulin Pump Recalled for 29,074 Units Worldwide (2026)

Medtronic MiniMed recalled 29,074 Paradigm Real-Time insulin pumps worldwide. The devices may deliver insulin improperly when the pump is elevated or lowered relative to the infusion site due to gravitational effects. Patients should stop using the pumps immediately and follow recall instructions from the manufacturer and their healthcare provider.

Feb 13, 2026

Medtronic MiniMed

All Medtronic